Dioxo- and oxovanadium(V) complexes of biomimetic hydrazone ONO and NNS donor ligands: Synthesis, crystal structure and catalytic reactivity

Oxo- and dioxo-vanadium(V) complexes of hydrazone ONO donor ligands with the formula [V^VO(μ₂-OCH₃)(L¹)]₂ (1) and [V^VO₂(L²)]·H₂O (2) were synthesized by the reaction of [VO(acac)₂] with proton-transfer complexes of benzenetricarboxylic acid/benzoylhydrazide and benzenetricarboxylic acid/isonicotinohydrazide, respectively (H₂L¹ = monocondensation of benzoylhydrazide and acetylacetone, H₂L² = monocondensation of isonicotinohydrazide and acetylacetone). Dioxo complex of V(V), [VO₂(L³)] (3), was synthesized by the reaction of equimolar amounts of VO(acac)₂, 2-acetylpyridine and thiosemicarbazide (H₂L³ = hydrazone Schiff base of acetylpyridine and thiosemicarbazide and Hacac = acetylacetone). They were characterized by FT-IR, UV-Vis and NMR spectroscopic methods. The crystal structures of 1 and 2 were determined by X-ray analyses. The ¹H NMR spectrum of the complex 1 in CDCl₃ solution indicated that this dimeric complex is converted appreciably into its respective monomeric form. The catalytic potential of the complexes has been tested for the oxidation of alkene, alkane and aromatic hydrocarbons using H₂O₂ as the terminal oxidant. Good to excellent conversions have been obtained for the oxidation of most of the hydrocarbons.     

Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes

Binuclear, mu-bis(oxo)bis{oxovanadium(V)} complexes [(VOL)2(mu-O)2](2 and 7)(where HL are the hydrazones Hacpy-nah I or Hacpy-fah II; acpy = 2-acetylpyridine, nah = nicotinic acid hydrazide and fah = 2-furoic acid hydrazide) were prepared by the reaction of [VO(acac)2] and the ligands in methanol followed by aerial oxidation. The paramagnetic intermediate complexes [VO(acac)(acpy-nah)](1) and [VO(acac)(acpy-fah)](6) have also been isolated. Treatment of [VO(acac)(acpy-nah)] and [VO(acac)(acpy-fah)] with aqueous H2O2 yields the oxoperoxovanadium(V) complexes [VO(O2)(acpy-nah)](3) and [VO(O2)(acpy-fah)](8). In the presence of catechol (H2cat) or benzohydroxamic acid (H2bha), 1 and 6 give the mixed chelate complexes [VO(cat)L](HL =I: 4, HL =II: 9) or [VO(bha)L](HL =I: 5, HL =II: 10). Complexes 4, 5, 9 and 10 slowly convert to the corresponding oxo-mu-oxo species 2 and 7 in DMF solution. Ascorbic acid enhances this conversion under aerobic conditions, possibly through reduction of these complexes with concomitant removal of coordinated catecholate or benzohydroxamate. Acidification of 7 with HCl dissolved in methanol afforded a hydroxo(oxo) complex. The crystal and molecular structure of 2.1.5H2O has been determined, and the structure of 7 re-determined, by single crystal X-ray diffraction. Both of these binuclear complexes contain the uncommon asymmetrical {VO(mu-O)}2 diamond core. The in vitro tests of the antiamoebic activity of ligands I and II and their binuclear complexes 2 and 7 against the protozoan parasite Entamoeba histolytica show that the ligands have no amoebicidal activity while their vanadium complexes 2 and 7 display more effective amoebicidal activity than the most commonly used drug metronidazole (IC50 values are 1.68 and 0.45 microM, respectively vs 1.81 microM for metronidazole). Complexes 2 and 7 catalyse the oxidation of styrene and ethyl benzene effectively. Oxidation of styrene, using H2O2 as an oxidant, gives styrene epoxide, 2-phenylacetaldehyde, benzaldehyde, benzoic acid and 1-phenyl-ethane-1,2-diol, while ethyl benzene yields benzyl alcohol, benzaldehyde and 1-phenyl-ethane-1,2-diol.     

Synthesis, characterization and reactivity of oxomolybdenum(V) complexes with ONS and NNS donors

The monomeric oxomolybdenum(V) complexes, [MoOLCl₂]1a-1d [HL = S-benzyl/methyl 3-(2-pyridyl)methylenedithiocarbazate (1a and1b), or N-methyl-S-benzyl/methyl 3-(2-hydroxy phenyl)methylenedithiocarbazate (1c and1d) are synthesized by the reaction of MoOCl ₅ ²⁻ with HL ligands. All these complexes show magnetic moment of about 1.7 B.M. The complexes,1a and1b, exhibit rhombicg-tensor anisotropy (like xanthine oxidase) whilst1c and1d show axial spectrum. The above complexes undergo irreversible electrochemical reduction furnishing Mo(IV) species and the potentials are dependent on the S-substituents. Reactions of MoOX ₅ ⁻ (X = Cl or Br) with H₂L¹ [H₂L¹ = S-methyl 3-(5-R-2-hydroxyphenyl)methylenedithiocarbazate] (R = H, CH₃, Cl, Br) produce complexes of thiolatobridged dimers, [Mo₂O₂L ₂ ¹ X₂], which show sub-normal magnetic moments at room temperature. The metal-centred irreversible oxidation and reduction of these complexes show expected dependence on the R-substituents of the salicyl phenyl ring of the ligands.     

Palladium(II) thiohydrazone complexes: synthesis,spectral characterization and antifungal study

Palladium(II) complexes of type [Pd(L)Cl₂] [where, L?=?benzaldehyde-1,1-diphenyl-2-thiohydrazone (L¹), salicylaldehyde-1,1-diphenyl-2-thiohydrazone (L²), acetaphenone-1,1-diphenyl-2-thiohydrazone (L³) and cyclohexanone-1,1-diphenyl-2-thiohydrazone (L⁴)] have been synthesized. The thiohydrazones can exist as thione-thiol tautomers and coordinate as a bidentate N–S ligand. The ligands are found to be monobasic bidentate. The complexes have been characterized by elemental analysis, IR, mass, electronic, ¹H NMR spectroscopic studies. In vitro antifungal studies against fungi Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger for some complexes have also been carried out.     

Synthesis, characterization, structures, and catalytic property of oxovanadium(V) complexes with hydrazone ligands

The reaction of [VO(Acac)₂] with 4-methyl-N′-[(2-hydroxy-1-naphthyl)methylidene]benzohydrazide (H₂L¹) and 4-methyl-N′-[1-(2-hydroxynaphthyl)ethyiidene]benzohydrazide (H₂L²), respectively, in methanol, affords two new oxovanadium(V) complexes [VO(OMe)L¹]₂ (I) and [VO(OMe)L²] (II). Both complexes have been characterized by elemental analysis, IR, and single crystal X-ray diffraction methods. Complex I is a methoxide-bridged dinuclear oxovanadium(V) compound, while complex II is a mononuclear oxovanadium(V) compound. The dinegative hydrazone ligands coordinate to the metal atoms through phenolate, imine, and deprotonated amide donor atoms. The geometry around vanadium atom in I is a distorted VNO₅ octahedron, while that in II is a VNO₄ square pyramid. Both complexes have effective catalytic property for the sulfoxidation reaction.     

Synthesis,spectral and EPR studies of oxovanadium(IV) complexes incorporating tridentate ONO donor hydrazone ligands: Structural study of one oxovanadium(V) complex

Five oxovanadium(IV) complexes of 2-hydroxy-4-methoxybenzaldehyde nicotinic acid hydrazone (H₂L¹), 2-hydroxy-4-methoxyacetophenone nicotinic acid hydrazone (H₂L²) and a binuclear oxovanadium(V) complex of H₂L² have been synthesized. These complexes were characterized by different physicochemical techniques like electronic, infrared and EPR spectral studies. The complexes [VOL¹]₂ · H₂O (1) and [VOL²]₂ · H₂O (4) are binuclear and [VOL¹bipy] (2), [VOL¹phen] · 1.5H₂O (3) and [VOL²phen] · 2H₂O (6) are heterocyclic base adducts and are EPR active. In frozen DMF at 77 K, all the oxovanadium(IV) complexes show axial anisotropy with two sets of eight line patterns. The complex [VOL² · OCH₃]₂ (5) is an unusual product and has distorted octahedral geometry, as obtained by X-ray diffraction studies.     

Nickel(II) complexes of ONS donor Schiff base ligands: synthesis,combined DFT-experimental characterization,redox, thermal,and in vitro biological investigation

This article reports the synthesis and characterization of four Ni(II) Schiff base complexes, [Ni(L)(H₂O)], where H₂L = N-(dehydroacetic acid)-thiosemicarbazide (H₂dha-tsc), N-(dehydroacetic acid)-4-methyl-3-thiosemicarbazide (H₂dha-mtsc), N-(dehydroacetic acid)-4-phenyl-3-thiosemicarbazide (H₂dha-ptsc), or N-(dehydroacetic acid)-4-phenylsemicarbazide (H₂dha-psc). The nature of bonding and stereochemistry of these complexes have been deduced from elemental analysis, infrared and electronic spectral studies, molar conductance, magnetic measurements, mass spectrometry, thermogravimetric analysis, ¹H NMR and ¹³C NMR studies, and cyclic voltammetry. The stabilities of the complexes were determined in both solid state and solution. Molecular geometry optimizations and vibrational frequency calculations were performed with Gaussian 09 software package using density functional theory (DFT) with B3LYP/6-311G for a ligand (dha-ptscH₂) and B3LYP/LANL2DZ combination for [Ni(dha-mtsc)(H₂O)]. Based on the combined experimental and theoretical studies, square planar geometry has been proposed for the Ni(II) complexes. The Schiff base ligands and their metal complexes were screened for antibacterial activities against gram-negative bacteria (Escherichia coli ) at different concentrations to get their minimum inhibition concentration values. The bactericidal activity was enhanced in metal complexes as compared to free ligands.     

Synthesis, characterization, reactivity, and catalytic potential of model vanadium(IV, V) complexes with benzimidazole-derived ONN donor ligands

Reaction between [VO(acac)(2)] and the ONN donor Schiff base Hsal-ambmz (I) (Hsal-ambmz = Schiff base obtained by the condensation of salicylaldehyde and 2-aminomethylbenzimidazole) resulted in the formation of the complexes [V(IV)O(acac)(sal-ambmz)] (1), [V(V)O(2)(acac-ambmz)] (2) (Hacac-ambmz = Schiff base derived from acetylacetone and 2-aminomethylbenzimidazole), and the known complex [V(IV)O(sal-phen)] (3) (H(2)sal-phen = Schiff base derived from salicylaldehyde and o-phenylenediamine). Similarly, [V(IV)O(acac)(sal-aebmz)] (7) has been isolated from the reaction with Hsal-aebmz (II) (Hsal-aebmz derived from salicylaldehyde and 2-aminoethylbenzimidazole). Aerial oxidation of the methanolic solutions/suspensions of 1 and 7 yielded the dioxovanadium(V) complexes [V(V)O(2)(sal-ambmz)] (4) and [V(V)O(2)(sal-aebmz)] (8), respectively. Reaction of VOSO(4) with II gave [{V(IV)O(sal-aebmz)}(2)SO(4)] (9) and [V(IV)O(sal-aebmz)(2)] (10), along with 3 and 8. Under similar reaction conditions, I gave only [{V(IV)O(sal-ambmz)}(2)SO(4)] (5) and 3 as major products. Treatment of 1 and 7 with benzohydroxamic acid (Hbha) yielded the mixed-chelate complexes [V(V)O(bha)(sal-ambmz)] (6) and [V(V)O(bha)(sal-aebmz)] (11). The crystal and molecular structures of 2, 3.1/2DMF, 7.1/4H(2)O, 8, 9.2H(2)O, 10, and 11 have been determined, confirming the ONN binding mode of the ligands. In complex 10, one of the ligands is coordinated through the azomethine nitrogen and phenolate oxygen only, leaving the benzimidazole group free. In the dinuclear complex 9, bridging functions are the phenolate oxygens from both of the ligands and two oxygens of the sulfato group. The unstable oxoperoxovanadium(V) complex [V(V)O(O(2))(sal-aebmz)] (12) has been prepared by treatment of 7 with aqueous H(2)O(2). Acidification of methanolic solutions of 7 and 10 lead to (reversible) protonation of the bemzimidazole, while 8 was converted to an oxo-hydroxo species. Complexes 2, 4, and 8 catalyze the oxidation of methyl phenyl sulfide to methyl phenyl sulfoxide and methyl phenyl sulfone, a reaction mimicking the sulfideperoxidase activity of vanadate-dependent haloperoxidases. These complexes are also catalytically active in the oxidation of styrene to styrene oxide, benzaldehyde, benzoic acid, and 1-phenylethane-1,2-diol.     

Synthesis,crystal structure and catalytic activity of ruthenium(II) carbonyl complexes containing ONO and ONS donor ligands

Diamagnetic ruthenium(II) complexes of the type [Ru(L)(CO)(B)(EPh₃)] [where E = As, B = AsPh₃; E = P, B = PPh₃, py (or) pip and L = dibasic tridentate ligands dehydroacetic acid semicarbazone (abbreviated as dhasc) or dehydroacetic acid phenyl thiosemicarbazone (abbreviated as dhaptsc)] were synthesized from the reaction of [RuHCl(CO)(B)(EPh₃)₂] (where E = As, B = AsPh₃; E = P, B = PPh₃, py (or) pip) with different tridentate chelating ligands derived from dehydroacetic acid with semicarbazide or phenylthiosemicarbazide. All the complexes have been characterized by elemental analysis, FT-IR, UV–Vis and ¹H NMR spectral methods. The coordination mode of the ligands and the geometry of the complexes were confirmed by single crystal X-ray crystallography of one of the complexes [Ru(dhaptsc)(CO)(PPh₃)₂] (5). All the complexes are redox active and are monitored by cyclic voltammetric technique. Further, the catalytic efficiency of one of the ruthenium complexes (5) was determined in the case of oxidation of primary and secondary alcohols into their corresponding aldehydes and ketones in the presence of N-methylmorpholine-N-oxide.     

Synthesis,crystal structures,and biological activity of oxovanadium(V) complexes with similar tridentate hydrazone ligands

Two new oxovanadium(V) complexes, [VOL¹(OEt)(EtOH)] (1) and [VOL²(OMe)(MeOH)] (2), were prepared by reaction of [VO(acac)₂] (where acac?=?acetylacetonate) with N′-(3-bromo-2-hydroxybenzylidene)-4-methylbenzohydrazide (H₂L¹) in ethanol and N′-(3-bromo-2-hydroxybenzylidene)-4-methoxybenzohydrazide (H₂L²) in methanol, respectively. Crystal and molecular structures of the complexes were determined by elemental analysis, infrared spectra, and single-crystal X-ray diffraction. The V ions have octahedral coordination. Thermal stability and the inhibition of urease of the complexes were studied.     

Synthesis, characterization, reactivity and catalytic activity of oxidovanadium(IV), oxidovanadium(V) and dioxidovanadium(V) complexes of benzimidazole modified ligands

The reaction between [V(IV)O(acac)(2)] and the ONN donor Schiff base obtained by the condensation of pyridoxal and 2-aminoethylbenzimidazole (Hpydx-aebmz, I) or 2-aminomethylbenzimidazole (Hpydx-ambmz, II) in equimolar amounts results in the formation of [V(IV)O(acac)(pydx-aebmz)] 1 and [V(IV)O(acac)(pydx-ambmz)] 2, respectively. The aerobic oxidation of the methanolic solution of 1 yielded [V(V)O(2)(pydx-aebmz)] 3 and its reaction with aqueous H(2)O(2) gave the oxidoperoxidovanadium(v) complex, [V(V)O(O(2))(pydx-aebmz)] 4. The formation of 4 in solution is also established by titrations of methanolic solutions of 1 with H(2)O(2). By titrating solutions of 3 and of 4 with aqueous H(2)O(2) several distinct V(V)-pydx-aebmz species also containing the peroxido ligand are detected. The full geometry optimization of all species envisaged was done using DFT methods for suitable model complexes. The (51)V NMR chemical shifts (δ(V)) have also been calculated, the theoretical data being used to support assignments of the experimental chemical shifts. The (51)V hyperfine coupling constants are calculated for 1, the obtained values being in good agreement with the experimental EPR data. Reaction between the V(IV)O(2+) exchanged zeolite-Y and Hpydx-aebmz and Hpydx-ambmz in refluxing methanol, followed by aerial oxidation results in the formation of the encapsulated V(V)O(2)-complexes, abbreviated herein as [V(V)O(2)(pydx-aebmz)]-Y 5 and [V(V)O(2)(pydx-ambmz)]-Y 6. The molecular structure of 1, determined by single crystal X-ray diffraction, confirms its distorted octahedral geometry with the ONN binding mode of the tridentate ligand, with one acetylacetonato group remaining bound to the V(IV)O-centre. Oxidation of styrene is investigated using some of these complexes as catalyst precursors with H(2)O(2) as oxidant. Under optimised reaction conditions for the conversion of styrene in acetonitrile, a maximum of 68% conversion of styrene (with [V(V)O(2)(pydx-aebmz)]-Y) and 65% (with [V(V)O(2)(pydx-ambmz)]-Y) is achieved in 6 h of reaction time. The selectivity of the various products is similar for both catalysts and follows the order: benzaldehyde (ca. 55%) > 1-phenylethane-1,2-diol > benzoic acid > styrene oxide > phenyl acetaldehyde. Speciation of the systems and plausible intermediates involved in the catalytic oxidation processes are established by UV-Vis, EPR, (51)V NMR and DFT studies. Both non-radical (Sharpless) and radical mechanisms of the olefin oxidations were theoretically studied, and the radical pathway was found to be even more favorable than the Sharpless mechanism.     

Synthesis, reactivity, and X-ray crystal structure of some mixed-ligand oxovanadium(V) complexes: first report of binuclear oxovanadium(V) complexes containing 4,4'-bipyridine type bridge

Reaction of the tridentate ONO Schiff-base ligand 2-hydroxybenzoylhydrazone of 2-hydroxybenzoylhydrazine (H2L) with VO(acac)2 in ethanol medium produces the oxoethoxovanadium(V) complex [VO(OEt)L] (A), which reacts with pyridine to form [VO(OEt)L.(py)] (1). Complex 1 is structurally characterized. It has a distorted octahedral O4N2 coordination environment around the V(V) acceptor center. Both complexes A and 1 in ethanol medium react with neutral monodentate Lewis bases 2-picoline, 3-picoline, 4- picoline, 4-amino pyridine, imidazole, and 4-methyl imidazole, all of which are stronger bases than pyridine, to produce dioxovanadium(V) complexes of general formula BH[VO2L]. Most of these dioxo complexes are structurally characterized, and the complex anion [VO2L]- is found to possess a distorted square pyramidal structure. When a solution/suspension of a BH[VO2L] complex in an alcohol (ROH) is treated with HCl in the same alcohol, it is converted into the corresponding monooxoalkoxo complex [VO(OR)L], where R comes from the alcohol used as the reaction medium. Both complexes A and 1 produce the 4,4'-bipyridine-bridged binuclear complex [VO(OEt)L]2(mu-4,4'-bipy) (2), which, to the best of our knowledge, represents the first report of a structurally characterized 4,4'-bipyridine-bridged oxovanadium(V) binuclear complex. Two similar binuclear oxovanadium(V) complexes 3 and 4 are also synthesized and characterized. All these binuclear complexes (2-4), on treatment with base B, produce the corresponding mononuclear dioxovanadium(V) complexes (5-10).     

Urease inhibition of oxovanadium(V) complexes with hydrazone and hydroxamate ligands

Two new oxovanadium(V) complexes, [VOL¹(SHA)] (I) and [VOL²(BHA)] (II), were prepared by the reaction of [VO(Acac)₂] (Acac = acetylacetonate) with N′-(2-hydroxybenzylidene)isonicotinohydrazide (H₂L¹) and salicylhydroxamic acid (HSHA) and 4-chloro-N′-(2-hydroxy-3-methoxybenzylidene)benzohydrazide (H₂L²) and benzohydroxamic acid (HBHA), respectively, in methanol. Crystal and molecular structures of the complexes were determined by elemental analysis, infrared spectra and single crystal X-ray diffraction (CIF file CCDC nos. 978238 (I) and 978392 (II)). The V atoms are in octahedral coordination. Thermal stability and the inhibition of urease of the complexes were studied.     

Six-coordinated oxovanadium(V) complexes of reduced Schiff bases derived from amino acids: synthesis,reactivity and redox studies

New oxovanadium(V) complexes, [VOL(hq)] (1)–(4) have been prepared by the reaction of [VO(acac)₂] with ligands LH₂ in the presence of 8-hydroxyquinoline (Hhq). LH₂ is the dibasic tridentate ONO Mannich base [(S)-H₂glysal, (S)-H₂alasal, (S)-H₂leusal and (S)-H₂ileusal; S represents the S-enantiomer] obtained by the reduction of the Schiff bases of salicylaldehyde (sal) and the amino acids: glycine (gly), DL-alanine (ala), leucine (leu) and isoleucine (ileu), respectively. Spectral studies suggest an octahedral structure for these complexes. The complexes exhibit a single ⁵¹V-n.m.r. signal at –464.6 to –468.0 p.p.m. due to the existence of a single isomeric species in solution. In the presence of L-ascorbic acid under aerobic conditions [VO(S-glysal)(hq)] (1) and [VO(S-isoleusal)(hq)] (4) are converted into the corresponding dioxo species possible via intermediate reduction. A time- dependent ⁵¹V-n.m.r. study has also been carried out in order to investigate the possible isomerisation and/or further reaction in solution.     

Template synthesis and characterization of oxovanadium(IV) complexes with tetraaza macrocyclic ligands and their activity on potato virus X

The oxovanadium(IV) complexes (I) of the type [VO(L)]SO₄ have been prepared using an in-situ method of synthesis with ligands derived from di-2-thienylethanedione with 1,2-diaminobenzene or 2,3-diaminopyridine. These parent complexes have been further reacted with μ-diketones to yield macrocyclic complexes (II) of types [VO(mac)]SO₄ (where mac = macrocyclic ligands derived by condensation of amino group of parent complex with μ-diketones), wherein the VO²⁺ cation acts as a template. Tentative structures of these complexes have been proposed on the basis of elemental analysis, electrical conductance, magnetic moments and spectral (infrared, electronic and electron spin resonance) data. The oxovanadium(IV) complexes are five coordinated wherein the tetraaza macrocyclic ligands act as tetradentate chelating agents. All the complexes are found to inhibit the infectivity of potato virus X, when checked using the test plant Chenopodium amaranticolor.     

Mixed-ligand oxovanadium(V) complexes incorporating bidentate salicylaldehyde and tridentate aldimine ligands

Summary Mixed-ligand oxovanadium(V) complexes, [V^VO(L)-(sal)], containing salicylaldimine ligands of -amino acids H₂L [(1);R = Me, i-Pr and CH₂Ph] and salicylaldehyde (Hsal) have been synthesized. The coordination sphere of the complexes is of the VO(ONO)(OO) type, where O atoms are phenolic, carboxylic and aldehydic, and N is of the azomethine type. The complexes are diamagnetic and exhibit only one LMCT band at ca. 490 nm. They display quasi-reversible one-electron reduction peaks in a CH₂Cl₂-MeCN (21v/v) mixture in the 0.07–0.13V versus s.c.e. range. A trend in the redox potential data has been rationalized on the basis of conventional normal substituent effects.     

Preparation,spectral characterization,electrochemistry, EXAFS,antibacterial and catalytic activity of new ruthenium (III) complexes containing ONS donor ligands with triphenylphosphine/arsine

New hexa‐coordinated ruthenium (III) complexes of the type [RuX(EPh₃)₂(L)] (X = Cl or Br; L = dibasic tridentate Schiff base ligand; E = P or As) have been synthesized by the reactions of [RuCl₃(PPh₃)₃], [RuCl₃(AsPh₃)₃] or [RuBr₃(AsPh₃)₃] with the appropriate Schiff base ligands derived by the condensation of salicylaldehyde and 2‐hydroxy‐1‐naphthaldehyde with N(4) substituted thiosemicarbazones. All the new complexes were characterized using various physico‐chemical methods such as elemental analyses, infrared, electron paramagnetic resonance (EPR) spectroscopy, magnetic moment and cyclic voltammetry. Based on the extended X‐ray absorption fine structure (EXAFS) analysis, an octahedral structure has been confirmed for the complexes. The new complexes have been subjected to the catalytic activity and antibacterial studies. Copyright © 2005 John Wiley & Sons, Ltd.     

Mixed-ligand metal complexes containing an ONS Schiff base and imidazole/benzimidazole ligands: synthesis,characterization, crystallography and biological activity

Salicylaldehyde-4-methylthiosemicarbazone (H₂MTSali) has been prepared via the condensation reaction of 4-methyl-3-thiosemicarbazide and salicylaldehyde. Four new mixed-ligand copper(II) and nickel(II) complexes with a general formula [M(MTSali)L] (M = Cu²⁺ or Ni²⁺; L = co-ligand) were synthesized, where L is either imidazole (im) or benzimidazole (bzim). The Schiff base and its mixed-ligand complexes were characterized by IR and UV/Vis spectroscopy, and the complexes by molar conductivity and magnetic susceptibility measurements. The spectroscopic data indicated that the Schiff base behaves as a tridentate ONS donor ligand coordinating via the phenoxide-oxygen, azomethine-nitrogen, and thiolate-sulphur atoms. Magnetic data indicate a square planar environment for the nickel(II) complexes while molar conductance values indicate that the metal complexes are essentially non-electrolytes in DMSO solution. X-ray crystallography shows Cu(MTSali)bzim (1) and Ni(MTSali)bzim (3) to be isostructural, with the metal(II) ions being coordinated by a N₂OS donor set that defines an approximate square planar geometry; in both cases, the benzimidazole is splayed with respect to the coordination plane. The copper(II) complexes were active against MDA-MB-231 and MCF-7 breast cancer cell lines, more so than H₂MTSali, whereas the nickel(II) complexes were inactive.     

Crystal structures of new isostructural oxovanadium(V) complexes with hydrazone ligands

Two new isostructural methoxide-bridged dimeric oxovanadium(V) complexes [VO(L¹)(OMe)]₂ (1) and [VO(L²)(OMe)]₂ (2), where L¹ and L² are the deprotonated forms of 3-bromo-N′-[1-(2-hydroxyphenyl)×ethylidene]benzohydrazide (H₂L¹) and 3-chloro-N′-[1-(2-hydroxyphenyl)ethylidene]benzohydrazide (H₂L²) respectively, are synthesized and characterized by elemental analyses, IR spectra, and single crystal X-ray determination. Both crystals crystallize in the triclinic space group P-1. For 1, a = 7.5237(15) Å, b = 10.846(3) Å, c = 11.195(3) Å, α = 84.143(3)°, β = 72.244(3)°, γ = 77.869(3)°, V = 849.9(4) ų, Z = 1, R ₁ = 0.0634, wR ₂ = 0.1373. For 2, a = 7.493(2) Å, b = 10.740(3) Å, c = 11.109(3) Å, α = 84.569(2)°, β = 71.783(2)°, γ = 79.822(2)°, V = 835.0(4) ų, Z = 1, R ₁ = 0.0511, wR ₂ = 0.1076. Each V atom in the complexes is octahedrally coordinated.